-
Volkswagen is preparing deeper restructuring as German factory pressure intensifies. Management wants further cost reductions ahead of a September board meeting, while labour representatives and Lower Saxony are pressing for alternatives.
-
The UK is widening the Bank of England’s innovation mandate. A proposed secondary objective would cover payments and digital money as stablecoin regulation and payment infrastructure move closer to implementation.
-
Science advisers want stronger government coordination for UK chemicals policy. The Council for Science and Technology is calling for a dedicated minister and a 12-month roadmap covering resilience, regulation, investment, and industrial competitiveness.
-
Ofgem will raise the household energy price cap this October. The 4% increase takes the typical annualised bill to £1,723 as higher international gas prices continue feeding into UK costs.
-
Low Rhine levels are disrupting freight and German industrial recovery. Britain’s second-largest trading partner now faces higher transport costs and material delays as drought squeezes one of Europe’s most important inland freight routes.
-
French regulators fined Boohoo over misleading online discounting practices today. Investigators also identified inaccurate product-material descriptions during their review of the retailer’s historic ecommerce operations.
-
Britain will impose provisional anti-dumping duties on Chinese boom lifts. Rates of between 16.25% and 71.74% will apply to affected imports while the Trade Remedies Authority completes its investigation.
-
CMA investigations put digital drip pricing under formal regulatory scrutiny. Trainline, Virgin Atlantic, and RED Driving School face scrutiny over whether mandatory charges were displayed clearly enough before customers completed purchases.
-
UK regulators have clarified the licensing route for microbiome medicines. The MHRA says emerging therapies can use existing medicines frameworks, while developers must address manufacturing consistency, safety, antimicrobial-resistance risks, and robust clinical evidence.
-
Fuel retailers remain under scrutiny as competitive pressure stays weak. The CMA found no evidence of deliberate crisis exploitation but remains concerned about high margins, slow wholesale-price pass-through, and local price differences.